Cite

HARVARD Citation

    Zinzani, P. et al. (2015). Brentuximab Vedotin in Transplant‐Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients. Oncologist. pp. 1413-1416. [Online]. 
  
Back to record